Travis Zack

Feb 12, 2024 | ascpt.onlinelibrary.wiley.com | Sarah B Doernberg |Travis Zack |Atul J. Butte |Anu Patel

WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? Electronic health records (EHRs) are a valuable source of real-world data that can be utilized for analysis of drug-related adverse events (AEs) not otherwise reliable from clinical trials or pharmacovigilance efforts. Machine learning is a prediction tool that can aid clinical decision making. WHAT QUESTION DID THIS STUDY ADDRESS?

Mar 23, 2023 | nature.com | Travis Zack |Atul J. Butte |Ghassan Abou Alfa |Kurt P. Losert

AbstractThe incidence and biochemical consequences of rare tumor subtypes are often hard to study. Fibrolamellar liver cancer (FLC) is a rare malignancy affecting adolescents and young adults. To better characterize the incidence and biochemical consequences of this disease, we combined a comprehensive analysis of the electronic medical record and national payer data and found that FLC incidence is likely five to eight times higher than previous estimates.